VanEck Pharmaceutical ETF PPH
Set alert
119.33 USD +2.41 +2.06%
At close · Oct 30
119.94 +0.61 +0.51%
After hours · Oct 30, 6:49 PM ET
118.97 Day range 120.86
92.35 52-week range 119.33
- YTD
- +15.66%
- 1 year
- +29.21%
- Open
- 119.73
- Prev close
- 116.92
- Mkt cap
- 1.07B
- Vol
- 1.28M
- Avg vol
- 306.18K
- EPS
- 4.37
- P/E
- 27.28
- Div yield
- 0.00%
More statistics
- Low
- 118.97
- High
- 120.86
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.00
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 112.51
- 200-d avg
- 107.85
30m chart
Built from the cached five-day intraday bars.
Signals (17)
| Name | Time | Ago |
|---|---|---|
| MACD: Sell Signal | Oct 30, 3:25 PM | 2 days ago |
| SMA: Bearish | Oct 30, 2:25 PM | 2 days ago |
| RSI: Overbought | Oct 30, 1:55 PM | 2 days ago |
| RSI: Overbought | Oct 30, 12:25 PM | 2 days ago |
| RSI: Overbought | Oct 30, 9:55 AM | 2 days ago |
| SMA: Bullish | Oct 29, 3:25 PM | 3 days ago |
| SMA: Bearish | Oct 29, 2:25 PM | 3 days ago |
| SMA: Bullish | Oct 29, 9:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:55 AM | 3 days ago |
| RSI: Overbought | Oct 29, 9:55 AM | 3 days ago |
| SMA: Bullish | Oct 28, 3:55 PM | 4 days ago |
| SMA: Bearish | Oct 28, 11:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 10:55 AM | 4 days ago |
| SMA: Bearish | Oct 27, 12:15 PM | 5 days ago |
| SMA: Bullish | Oct 27, 10:55 AM | 5 days ago |
| SMA: Bearish | Oct 27, 10:25 AM | 5 days ago |
| SMA: Bullish | Oct 26, 3:55 PM | 6 days ago |
Key statistics
- Market cap
- 0
- Enterprise value
- 0
- Trailing P/E
- 27.28
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.00
- EPS (TTM)
- 0.00
- Beta
- 0.00
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Shares outstanding
- 0
- Short % of float
- 0.00%
- 50-day average
- 112.51
- 200-day average
- 107.85
About VanEck Pharmaceutical ETF
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
News
- Can GLP-1s Fatten Your Portfolio? We Examine the VanEck Pharmaceutical ETF vs State Street SPDR Pharmaceuticals ETF
- PPH: Key Pharmaceutical Innovations Support Bullish Outlook (Upgrade)
- Which Pharmaceutical ETF Is the Better Buy: iShares’ Domestic IHE or VanEck’s Global PPH?
- Which Healthcare ETF Is the Better Buy: Simplify's Active PINK or VanEck's Pharma-Focused PPH?
- Execution of Pharma Tariffs Brings These ETFs Into Focus
- Should You Invest in the VanEck Pharmaceutical ETF (PPH)?
- Better Pharmaceuticals ETF: VanEck's PPH vs. Invesco PJP
- VanEck Pharmaceutical ETF vs VanEck Biotech ETF: Which Fund Is Better for Drug Innovation Profits?
- Should You Bet Big on Drugmakers? VanEck Pharmaceutical ETF vs.
- Healthcare ETFs to Watch Post Merck-Moderna Cancer Vaccine Breakthrough
Your note
Sign in to keep a note on PPH — it syncs with the Stock Master app.